Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products

Am J Respir Crit Care Med. 2021 Aug 1;204(3):359-362. doi: 10.1164/rccm.202104-1070LE.

Authors

Natacha Kapandji¹, Elise Yvin^{1

2}, Magali Devriese^{1

2}, Constance de Margerie-Mellon^{1

2}, Giulia Moratelli¹, Virginie Lemiale¹, Matthieu Jabaudon³, Elie Azoulay^{1

2}, Jean-Michel Constantin⁴, Guillaume Dumas^{1

2}

Affiliations

¹ Hôpital Saint-Louis Paris, France.
² Université de Paris Paris, France.
³ CHU ClermontFerrand and Université Clermont Auvergne ClermontFerrand, France.
⁴ Sorbonne University and PitiéSalpêtrière Hospital Paris, France.

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Acute Lung Injury / etiology*
Aged
Biomarkers / blood
COVID-19 / complications
COVID-19 / epidemiology
COVID-19 / physiopathology*
Epithelial Cells / drug effects*
Female
France / epidemiology
Glycation End Products, Advanced / blood*
Humans
Male
Middle Aged
Receptor for Advanced Glycation End Products / blood*
Respiratory Distress Syndrome / etiology*
Respiratory Distress Syndrome / physiopathology*
SARS-CoV-2

Substances

Biomarkers
Glycation End Products, Advanced
Receptor for Advanced Glycation End Products